34918950 31973235 32899678 33580091 32739033 36080443 31191542 33761251 32316328 31540271 31653030 33970442 33399457 34803455 36361598 33054155 35027551 33781002 31668465 32794211 35575910 33979150 34151302 35340605 33863856 36770918 34758399 3511594 - Search Results

Year	Number of Results
2019	29
2020	67
2021	63
2022	50
2023	9

1

Endocannabinoid System of the Blood-Brain Barrier: Current Understandings and Therapeutic Potentials.

Hagan K, Varelas P, Zheng H. Hagan K, et al. Cannabis Cannabinoid Res. 2022 Oct;7(5):561-568. doi: 10.1089/can.2021.0101. Epub 2021 Dec 16. Cannabis Cannabinoid Res. 2022. PMID: 34918950 Review.

2

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease.

Kelly R, Joers V, Tansey MG, McKernan DP, Dowd E. Kelly R, et al. Molecules. 2020 Jan 21;25(3):453. doi: 10.3390/molecules25030453. Molecules. 2020. PMID: 31973235 Free PMC article. Review.

3

Understanding the Medical Chemistry of the Cannabis Plant is Critical to Guiding Real World Clinical Evidence.

Ladha KS, Ajrawat P, Yang Y, Clarke H. Ladha KS, et al. Molecules. 2020 Sep 4;25(18):4042. doi: 10.3390/molecules25184042. Molecules. 2020. PMID: 32899678 Free PMC article. Review.

4

Cholesterol as a modulator of cannabinoid receptor CB₂ signaling.

Yeliseev A, Iyer MR, Joseph TT, Coffey NJ, Cinar R, Zoubak L, Kunos G, Gawrisch K. Yeliseev A, et al. Sci Rep. 2021 Feb 12;11(1):3706. doi: 10.1038/s41598-021-83245-6. Sci Rep. 2021. PMID: 33580091 Free PMC article.

5

Structural and Functional Insights into Cannabinoid Receptors.

Li X, Shen L, Hua T, Liu ZJ. Li X, et al. Trends Pharmacol Sci. 2020 Sep;41(9):665-677. doi: 10.1016/j.tips.2020.06.010. Epub 2020 Jul 29. Trends Pharmacol Sci. 2020. PMID: 32739033 Review.

6

Structure-Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074.

Amato G, Vasukuttan V, Harris D, Laudermilk L, Lucitti J, Runyon S, Maitra R. Amato G, et al. Molecules. 2022 Sep 2;27(17):5672. doi: 10.3390/molecules27175672. Molecules. 2022. PMID: 36080443 Free PMC article.

7

Modulation of Mast Cell Reactivity by Lipids: The Neglected Side of Allergic Diseases.

Hagemann PM, Nsiah-Dosu S, Hundt JE, Hartmann K, Orinska Z. Hagemann PM, et al. Front Immunol. 2019 May 29;10:1174. doi: 10.3389/fimmu.2019.01174. eCollection 2019. Front Immunol. 2019. PMID: 31191542 Free PMC article. Review.

8

Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists.

Jiang S, Iliopoulos-Tsoutsouvas C, Tong F, Brust CA, Keenan CM, Raghav JG, Hua T, Wu S, Ho JH, Wu Y, Grim TW, Zvonok N, Thakur GA, Liu ZJ, Sharkey KA, Bohn LM, Nikas SP, Makriyannis A. Jiang S, et al. J Med Chem. 2021 Apr 8;64(7):3870-3884. doi: 10.1021/acs.jmedchem.0c02053. Epub 2021 Mar 24. J Med Chem. 2021. PMID: 33761251

9

A Guide to Targeting the Endocannabinoid System in Drug Design.

Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. Stasiulewicz A, et al. Int J Mol Sci. 2020 Apr 16;21(8):2778. doi: 10.3390/ijms21082778. Int J Mol Sci. 2020. PMID: 32316328 Free PMC article. Review.

10

Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.

Porter RF, Szczesniak AM, Toguri JT, Gebremeskel S, Johnston B, Lehmann C, Fingerle J, Rothenhäusler B, Perret C, Rogers-Evans M, Kimbara A, Nettekoven M, Guba W, Grether U, Ullmer C, Kelly MEM. Porter RF, et al. Molecules. 2019 Sep 13;24(18):3338. doi: 10.3390/molecules24183338. Molecules. 2019. PMID: 31540271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results